Home / Learn / Precision Medicine / Cancer Diagnostics / Integration of Pathology with the Cancer Care Team / Program Resources

Program Resources

For cancer programs interested in improving the integration of pathology with cancer care delivery, the first step is completing the Self-Assessment Tool. Once your assessment is complete, return to this page to review resources to support your improvement plan(s). Resources include scientific publications, clinical practice guidelines, program standards, templates, and other references in each of the areas below.

Pathology and the Cancer Program

American College of Surgeons. Cancer Program Standards: Ensuring Patient-Centered Care. 2016 ed.
Choi SM, Lee AR, Choe JY, et al. Adequacy criteria of rapid on-site evaluation for endobronchial ultrasound-guided transbronchial needle aspiration: a simple algorithm to assess the adequacy of ROSE. Ann Thorac Surg. 2016;101(2):444-50.
El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014:e461-6.
Keating NL, Landrum MB, Lamont EB, et al. Tumor boards and the quality of cancer care. J Natl Cancer Inst. 2013;105(2):113–121.
Mallya V, Kumar SP, Meganathan P, Shivkumar S, Mehta R. The utility of ROSE (rapid on-site evaluation) in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA): Is the picture rosy? J Cytol. 2015;32(4):230-3.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press; September 11, 2018.
Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev. 2016;42:56-72.
Righi L, Franzi F, Montarolo F, Gatti G, Bongiovanni M, Sessa F, La Rosa S. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)—from morphology to molecular testing. J Thorac Dis. 2017;9(Suppl 5):S395-S404.
Volynskaya Z, Chow H, Evans A, Wolff A, Lagmay-Traya C, Asa SL. Integrated pathology informatics enables high-quality personalized and precision medicine: digital pathology and beyond. Arch Pathol Lab Med. 2018;142(3):369-382.
Weiss RL, Hassell LA, Parks ER. Progress toward improved leadership and management training in pathology. Arch Pathol Lab Med. 2014;138(4):492-7.

Lung Cancer

Choi SM, Lee AR, Choe JY, et al. Adequacy criteria of rapid on-site evaluation for endobronchial ultrasound-guided transbronchial needle aspiration: a simple algorithm to assess the adequacy of ROSE. Ann Thorac Surg. 2016;101(2):444-50.
College of American Pathologists (CAP). Cancer Protocol Templates.
Lim C, Tsao MS, Le LW, et al. Biomarker testing and time to treatment decision in patients with advanced non small-cell lung cancer. Ann Oncol. 2015;26(7):1415-21.
Lindeman NI, Cagle PT, Aisner DL, et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Arch Pathol Lab Med. 2018;142(3):321-346.
Mallya V, Kumar SP, Meganathan P, Shivkumar S, Mehta R. The utility of ROSE (rapid on-site evaluation) in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA): Is the picture rosy? J Cytol. 2015;32(4):230-3.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press; September 11, 2018.
NCCN Guidelines: Non-Small Cell Lung Cancer. Version 5.2019.
NCCN Guidelines: Small Cell Lung Cancer. Version 2.2019.
Prouty CD, Mazor KM, Greene SM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-30.
Righi L, Franzi F, Montarolo F, Gatti G, Bongiovanni M, Sessa F, La Rosa S. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)—from morphology to molecular testing. J Thorac Dis. 2017;9(Suppl 5):S395-S404.

Breast Cancer

College of American Pathologists (CAP). Cancer Protocol Templates.
King E, Mahon SM. Genetic testing: challenges and changes in testing for hereditary cancer syndromes. Clin J Oncol Nurs. 2017;21(5):589-598.
Middleton LP, Price KM, Puig P, et al. Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 guideline recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases. Arch Pathol Lab Med. 2009; 133(5):775-80.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press; September 11, 2018.
NCCN Guidelines: Breast Cancer. Version 2.2019.
NCCN Guidelines: Genetic/familial high-risk assessment: breast and ovarian. Version 3.2019.
Prouty CD, Mazor KM, Greene SM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-30.
Tomaszewski JE, Bear HD, Connally JA,et al. Consensus conference on second opinions in diagnostic anatomic pathology. Am J Clin Pathol. 2000;114:329-335.
Wolff AC, Hammond MEH, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update. J Clin Oncol. 2018; 36(20):2105-2122.

Prostate Cancer

Alford AV, Brito JM, Yadav KK, Yadav SS, Tewari AK, Renzulli J. The use of biomarkers in prostate cancer screening and treatment. Rev Urol. 2017;19(4):221-234.
College of American Pathologists (CAP). Cancer Protocol Templates.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press; September 11, 2018.
NCCN Guidelines: Prostate Cancer. Version 2.2019.
Prouty CD, Mazor KM, Greene SM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-30.
Tomaszewski JE, Bear HD, Connally JA, et al. Consensus conference on second opinions in diagnostic anatomic pathology. Am J Clin Pathol. 2000;114:329-335.

Colorectal Cancer

College of American Pathologists (CAP). Cancer Protocol Templates.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press; September 11, 2018.
NCCN Guidelines: Colon Cancer. Version 2.2019.
NCCN Guidelines: Rectal Cancer. Version 2.2019.
Prouty CD, Mazor KM, Greene SM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-30.
Sepulveda AR, Hamilton SR, Allegra CJ, et al. Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Mol Diagn. 2017;19(2):187-225.
Stoffel EM, Mangu PB, Gruber SB, et al; American Society of Clinical Oncology; European Society of Clinical Oncology. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;10;33(2):209-17.
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223-263.
Tomaszewski JE, Bear HD, Connally JA, et al. Consensus conference on second opinions in diagnostic anatomic pathology. Am J Clin Pathol. 2000;114:329-335.

Hematologic Malignancies

Arber DA, Borowitz MJ, Cessna M, et al. Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017;141(10):1342-1393.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum. Improving cancer diagnosis and care: patient access to oncologic imaging and pathology expertise and technologies: proceedings of a workshop. Washington, DC: National Academies Press September 11, 2018.
NCCN Guidelines: Acute Lymphoblastic Leukemia. Version 2.2019.
NCCN Guidelines: Acute Myeloid Leukemia. Version 3.2019.
NCCN Guidelines: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Version 5. 2019.
NCCN Guidelines: Chronic Myeloid Leukemia. Version 1.2019.
NCCN Guidelines: Hodgkin Lymphoma. Version 1.2019.
NCCN Guidelines: B-Cell Lymphomas. Version 4.2019.
NCCN Guidelines: T-Cell Lymphomas. Version 2.2019.
NCCN Guidelines: Multiple Myeloma. Version 3.2019.
Prouty CD, Mazor KM, Greene SM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-30.
Sever C, Abbott CL, de Baca ME, et al. Bone marrow synoptic reporting for hematologic neoplasms: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med. 2016;140(9):932-49.
Tomaszewski JE, Bear HD, Connally JA, et al. Consensus conference on second opinions in diagnostic anatomic pathology. Am J Clin Pathol. 2000;114:329-335.

Pathology Lab Management

Brown RW, Della Speranza V, Alvarez JO, et al. Uniform labeling of blocks and slides in surgical pathology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center and the National Society for Histotechnology. Arch Pathol Lab Med. 2015;139(12):1515-24.
Fitzgibbons PL, Bradley LA, Fatheree LA, et al; College of American Pathologists Pathology and Laboratory Quality Center. Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med. 2014;138(11):1432-43.
Jones BA, Darcy T, Souers RJ, Meier FA. Staffing benchmarks for clinical laboratories: a College of American Pathologists Q-Probes study of laboratory staffing at 98 institutions. Arch Pathol Lab Med. 2012;136(2):140-7.
Jones RG, Johnson OA, Batstone G. Informatics and the clinical laboratory. Clin Biochem Rev. 2014;35(3):177-192.
Nakhleh RE, Myers JL, Allen TC, et al. Consensus statement on effective communication of urgent diagnoses and significant, unexpected diagnoses in surgical pathology and cytopathology from the College of American Pathologists and Association of Directors of Anatomic and Surgical Pathology. Arch Pathol Lab Med. 2012;136(2):148-54.
Nakhleh RE, Nosé V, Colasacco C, et al. Interpretive diagnostic error reduction in surgical pathology and cytology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology. Arch Pathol Lab Med. 2016;140(1):29-40.
Weiss RL, Hassell LA, Parks ER. Progress toward improved leadership and management training in pathology. Arch Pathol Lab Med. 2014;138(4):492-7.

Share

In This Section

Program Resources